期刊文献+

生殖器疣活检标本中HPV多重检测技术的建立

Establishments of multiple methods for the detection and typing of HPV in genital warts lesions
原文传递
导出
摘要 目的探索生殖器疣活检标本中人乳头瘤病毒(HPV)的多重检测分型技术,为我国生殖器疣感染HPV的检测和分型研究的开展提供有效手段。方法针对病毒L1区基因序列自行设计通用引物MY09、MY11、GP5+和GP6+,并对反应条件进行优化,建立基于聚合酶链式反应(PCR)及序列分析的检测生殖器疣活检标本中HPV感染型别的方法。结果采用巢氏PCR方法能够特异扩出140bp的目的条带,实现HPV感染的定性检测;通过对目的基因片段的测序分析能够实现单型别感染/多型别复合感染HPV的分型和鉴定,并可以检测到HPV少见的特殊类型,同时也能提供已知的HPV型别的突变信息。结论基于HPV病毒L1区基因序列建立的PCR和序列分析检测技术是快速检测和分型生殖器疣活检标本中HPV的一种有效方法。 Objective To develop an effective method for the detection of human papilloma virus (HPV) in genital warts lesions,and to provide standard techniques for the detection of HPV infection of genital warts in a multi-center clinical-epidemiology study. Methods Several pairs of oligo-nucleotide primers (MY09,MY11,GP5+ and GP6+) were designed and synthesized to amplify the specific DNA sequences by multiple PCR..Moreover,the reaction conditions of multiple PCR were optimized. Results The developed multiple PCR method could specifically amplify the expected sequences (140 bp)for HPV..Both the single-type and multiple-type HPV infection were successful detected,including the rare HPV strains and mutants. Conclusion A specific,sensitive,rapid and reliable PCR method was developed for the detection of HPV in genital warts lesions.
出处 《热带医学杂志》 CAS 2012年第4期440-442,471,共4页 Journal of Tropical Medicine
基金 广东省科技计划项目(2010B031900004)
关键词 生殖器疣 人乳头瘤病毒 基因分型 多重检测 genital warts human papilloma virus typing analysis multiple-detecting methods
  • 相关文献

参考文献11

二级参考文献56

  • 1黄庆,府伟灵,周玉,张雪,黄君富,陈斌.基因芯片对人乳头瘤病毒的快速检测和分型[J].中华医院感染学杂志,2005,15(4):476-478. 被引量:50
  • 2刘元林,刘荣卿,陈鸿书.人乳头瘤病毒及癌基因在人生殖器癌发生中的作用[J].临床皮肤科杂志,1995,24(4):216-218. 被引量:5
  • 3Clifford GM, Smith JS, Plummer M, et al. Human papillomavims types in invasive cervical cancer worldwide: a meta-analysis [J]. Br J Cancer, 2003, 88(1):63-73.
  • 4Tovar JM, Bazaldua OV, Vargas L, et al. Human papillomavirus, cervical cancer, and the vaccines [ J]. Postgrad Med, 2008, 120(2) :79-84.
  • 5Wang KL. Human papiUomavirus and vaccination in cervical cancer [J]. Taiwan J Obstet Gynecol, 2007, 46(4) :352-362.
  • 6Gillison ML. Human papillomavims-related diseases: ompharynx cancers and potential implications for adolescent HPV vaccination [J]. J Adolesc Health, 2008, 43(4 Suppl) :S52-60.
  • 7Dinh TA, Benoit MF. Human papillomavirus vaccine: progress and the future [J]. Expert Opin Biol Ther, 2007, 7(4) :479- 485.
  • 8Harro CD, Pang YY, Roden RB, et al. Safety and immunogenicity trial in adult volunteers of a human papillomavirus 16 L1 virus-like particle vaccine [ J]. J Natl Cancer Inst, 2001, 93 (4) :284-292.
  • 9Harper DM, Franco EL, Wheeler CM, et al. Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18 : follow-up from a randomized control trial [ J ]. Lancet, 2006, 367 ( 9518 ) : 1247-1255.
  • 10Munoz N, Bosch FX, Castellsague X, et al. Against which human papillomavirus types shall we vaccinate and screen? The international perspective [ J]. Int J Cancer, 2004, 111 (2) :278- 285.

共引文献73

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部